$96.12
0.580.61%
At Close: -
$95.70
-0.42-0.44%
After Hours: 4:03 PM EDT
15 minutes delayed
Colgate-Palmolive
CLNYSE
Colgate-Palmolive (NYSE:CL) Stock, Analyst Ratings, Price Targets, Predictions
Colgate-Palmolive Co has a consensus price target of $84.52, established from looking at the 78 latest analyst ratings. The last 3 analyst ratings were released from Exane BNP Paribas, Morgan Stanley, and Argus Research on June 24, 2024, May 28, 2024, and May 15, 2024. With an average price target of $106.33 between Exane BNP Paribas, Morgan Stanley, and Argus Research, there's an implied 11.11% upside for Colgate-Palmolive Co from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Exane BNP Paribas
Morgan Stanley
Argus Research
Barclays
Wells Fargo
1calculated from analyst ratings
Analyst Ratings for Colgate-Palmolive
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/24/2024 | Buy Now | 13.9% | Exane BNP Paribas | Kevin Grundy | → $109 | Initiates | → Outperform | Get Alert |
| 05/28/2024 | Buy Now | 7.63% | Morgan Stanley | Dara Mohsenian | $101 → $103 | Maintains | Overweight | Get Alert |
| 05/15/2024 | Buy Now | 11.81% | Argus Research | Chris Graja | $97 → $107 | Maintains | Buy | Get Alert |
| 04/30/2024 | Buy Now | -11.18% | Barclays | Lauren Lieberman | $84 → $85 | Maintains | Equal-Weight | Get Alert |
| 04/29/2024 | Buy Now | -3.87% | Wells Fargo | Chris Carey | $90 → $92 | Maintains | Equal-Weight | Get Alert |
| 04/29/2024 | Buy Now | -0.73% | Stifel | Mark Astrachan | $94 → $95 | Maintains | Buy | Get Alert |
| 04/29/2024 | Buy Now | 4.49% | B of A Securities | Bryan Spillane | $90 → $100 | Maintains | Buy | Get Alert |
| 04/29/2024 | Buy Now | -0.73% | RBC Capital | Nik Modi | $88 → $95 | Maintains | Sector Perform | Get Alert |
| 04/16/2024 | Buy Now | 4.49% | Citigroup | Filippo Falorni | $95 → $100 | Maintains | Buy | Get Alert |
| 04/12/2024 | Buy Now | -12.23% | Barclays | Lauren Lieberman | $82 → $84 | Maintains | Equal-Weight | Get Alert |
| 04/10/2024 | Buy Now | -1.78% | Stifel | Mark Astrachan | $89 → $94 | Maintains | Buy | Get Alert |
| 04/08/2024 | Buy Now | 0.31% | Evercore ISI Group | Robert Ottenstein | $90 → $96 | Maintains | Outperform | Get Alert |
| 03/01/2024 | Buy Now | -2.82% | Goldman Sachs | Jason English | → $93 | Reinstates | → Buy | Get Alert |
| 01/29/2024 | Buy Now | -2.82% | Morgan Stanley | Dara Mohsenian | $85 → $93 | Maintains | Overweight | Get Alert |
| 01/29/2024 | Buy Now | -0.73% | UBS | Peter Grom | $93 → $95 | Maintains | Buy | Get Alert |
| 01/29/2024 | Buy Now | -8.05% | Wells Fargo | Chris Carey | $80 → $88 | Maintains | Equal-Weight | Get Alert |
| 01/29/2024 | Buy Now | -4.91% | Raymond James | Olivia Tong | → $91 | Upgrade | Market Perform → Outperform | Get Alert |
| 01/18/2024 | Buy Now | -5.96% | JP Morgan | Andrea Teixeira | $88 → $90 | Maintains | Overweight | Get Alert |
| 01/16/2024 | Buy Now | -14.32% | Barclays | Lauren Lieberman | $75 → $82 | Maintains | Equal-Weight | Get Alert |
| 12/15/2023 | Buy Now | -5.96% | B of A Securities | Bryan Spillane | → $90 | Upgrade | Neutral → Buy | Get Alert |
| 11/29/2023 | Buy Now | -8.05% | JP Morgan | Andrea Teixeira | $83 → $88 | Maintains | Overweight | Get Alert |
| 11/13/2023 | Buy Now | -9.09% | Jefferies | Kaumil Gajrawala | → $87 | Initiates | → Buy | Get Alert |
| 10/30/2023 | Buy Now | -16.41% | RBC Capital | Nik Modi | $79 → $80 | Maintains | Sector Perform | Get Alert |
| 10/30/2023 | Buy Now | -11.18% | Morgan Stanley | Dara Mohsenian | $89 → $85 | Maintains | Overweight | Get Alert |
| 10/17/2023 | Buy Now | -21.63% | B of A Securities | Bryan Spillane | $85 → $75 | Maintains | Neutral | Get Alert |
| 10/16/2023 | Buy Now | -15.36% | Stifel | Mark Astrachan | $85 → $81 | Upgrade | Hold → Buy | Get Alert |
| 10/12/2023 | Buy Now | -23.72% | Barclays | Lauren Lieberman | $81 → $73 | Maintains | Equal-Weight | Get Alert |
| 10/12/2023 | Buy Now | -15.36% | JP Morgan | Andrea Teixeira | $85 → $81 | Maintains | Overweight | Get Alert |
| 10/11/2023 | Buy Now | -11.18% | Citigroup | Filippo Falorni | $92 → $85 | Maintains | Buy | Get Alert |
| 09/22/2023 | Buy Now | -12.23% | HSBC | Alejandro Zamacona | → $84 | Initiates | → Buy | Get Alert |
| 08/01/2023 | Buy Now | -15.36% | Barclays | Lauren Lieberman | $77 → $81 | Maintains | Equal-Weight | Get Alert |
| 07/31/2023 | Buy Now | -13.27% | RBC Capital | Nik Modi | → $83 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 07/31/2023 | Buy Now | -4.91% | Deutsche Bank | Steve Powers | $88 → $91 | Maintains | Buy | Get Alert |
| 05/01/2023 | Buy Now | -11.18% | B of A Securities | Bryan Spillane | $80 → $85 | Maintains | Neutral | Get Alert |
| 05/01/2023 | Buy Now | -4.91% | Evercore ISI Group | Robert Ottenstein | $85 → $91 | Maintains | Outperform | Get Alert |
| 05/01/2023 | Buy Now | -13.27% | RBC Capital | Nik Modi | $82 → $83 | Maintains | Sector Perform | Get Alert |
| 05/01/2023 | Buy Now | 0.31% | Goldman Sachs | Jason English | $86 → $96 | Maintains | Buy | Get Alert |
| 05/01/2023 | Buy Now | -7% | Morgan Stanley | Dara Mohsenian | $82 → $89 | Maintains | Overweight | Get Alert |
| 05/01/2023 | Buy Now | -15.36% | Wells Fargo | Chris Carey | $76 → $81 | Maintains | Equal-Weight | Get Alert |
| 05/01/2023 | Buy Now | -3.87% | Citigroup | Filippo Falorni | $88 → $92 | Maintains | Buy | Get Alert |
| 03/29/2023 | Buy Now | -10.14% | UBS | Peter Grom | $84 → $86 | Maintains | Buy | Get Alert |
| 03/20/2023 | Buy Now | -16.41% | Deutsche Bank | Steve Powers | $84 → $80 | Maintains | Buy | Get Alert |
| 02/17/2023 | Buy Now | -12.23% | Citigroup | Filippo Falorni | → $84 | Initiates | → Buy | Get Alert |
| 01/31/2023 | Buy Now | -19.54% | Barclays | Lauren Lieberman | $80 → $77 | Maintains | Equal-Weight | Get Alert |
| 01/30/2023 | Buy Now | -20.59% | Wells Fargo | Chris Carey | $80 → $76 | Maintains | Equal-Weight | Get Alert |
| 01/30/2023 | Buy Now | -14.32% | Morgan Stanley | Dara Mohsenian | → $82 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 01/13/2023 | Buy Now | -10.14% | JP Morgan | Andrea Teixeira | $81 → $86 | Maintains | Overweight | Get Alert |
| 01/03/2023 | Buy Now | -16.41% | Wells Fargo | Chris Carey | $75 → $80 | Maintains | Equal-Weight | Get Alert |
| 12/06/2022 | Buy Now | -9.09% | Deutsche Bank | Steve Powers | $85 → $87 | Maintains | Buy | Get Alert |
| 11/22/2022 | Buy Now | — | Wolfe Research | Greg Badishkanian | — | Initiates | → Peer Perform | Get Alert |
| 11/01/2022 | Buy Now | -20.59% | Barclays | Lauren Lieberman | $72 → $76 | Maintains | Equal-Weight | Get Alert |
| 10/18/2022 | Buy Now | -11.18% | Credit Suisse | Kaumil Gajrawala | $88 → $85 | Maintains | Outperform | Get Alert |
| 10/17/2022 | Buy Now | -11.18% | Deutsche Bank | Steve Powers | $87 → $85 | Maintains | Buy | Get Alert |
| 10/13/2022 | Buy Now | -17.45% | JP Morgan | Andrea Teixeira | → $79 | Upgrade | Neutral → Overweight | Get Alert |
| 10/10/2022 | Buy Now | -15.36% | Goldman Sachs | Jason English | $91 → $81 | Maintains | Buy | Get Alert |
| 10/03/2022 | Buy Now | -21.63% | Wells Fargo | Chris Carey | $80 → $75 | Maintains | Equal-Weight | Get Alert |
| 08/02/2022 | Buy Now | -22.68% | Barclays | Lauren Lieberman | $71 → $74 | Maintains | Equal-Weight | Get Alert |
| 08/01/2022 | Buy Now | -5.96% | UBS | Peter Grom | $88 → $90 | Maintains | Buy | Get Alert |
| 08/01/2022 | Buy Now | -16.41% | Wells Fargo | Chris Carey | $71 → $80 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 07/21/2022 | Buy Now | -18.5% | JP Morgan | Andrea Teixeira | $79 → $78 | Maintains | Neutral | Get Alert |
| 05/23/2022 | Buy Now | -25.81% | Barclays | Lauren Lieberman | $77 → $71 | Maintains | Equal-Weight | Get Alert |
| 05/03/2022 | Buy Now | -19.54% | Barclays | Lauren Lieberman | $81 → $77 | Maintains | Equal-Weight | Get Alert |
| 05/03/2022 | Buy Now | -16.41% | Atlantic Equities | Edward Lewis | $92 → $80 | Downgrade | Overweight → Neutral | Get Alert |
| 05/02/2022 | Buy Now | -8.05% | Deutsche Bank | Steve Powers | $91 → $88 | Maintains | Buy | Get Alert |
| 05/02/2022 | Buy Now | -14.32% | Morgan Stanley | Dara Mohsenian | $91 → $82 | Maintains | Equal-Weight | Get Alert |
| 05/02/2022 | Buy Now | -14.32% | RBC Capital | Nik Modi | $84 → $82 | Maintains | Sector Perform | Get Alert |
| 04/13/2022 | Buy Now | -4.91% | Deutsche Bank | Steve Powers | $90 → $91 | Maintains | Buy | Get Alert |
| 04/08/2022 | Buy Now | — | Raymond James | Olivia Tong | — | Initiates | → Market Perform | Get Alert |
| 04/01/2022 | Buy Now | -15.36% | Barclays | Lauren Lieberman | $90 → $81 | Maintains | Equal-Weight | Get Alert |
| 03/30/2022 | Buy Now | -15.36% | JP Morgan | Andrea Teixeira | $86 → $81 | Maintains | Neutral | Get Alert |
| 02/02/2022 | Buy Now | -13.27% | Bernstein | Callum Elliott | $77 → $83 | Upgrade | Underperform → Market Perform | Get Alert |
| 01/31/2022 | Buy Now | -5.96% | Credit Suisse | Kaumil Gajrawala | $95 → $90 | Maintains | Outperform | Get Alert |
| 01/31/2022 | Buy Now | -4.91% | Morgan Stanley | Dara Mohsenian | $90 → $91 | Maintains | Equal-Weight | Get Alert |
| 12/16/2021 | Buy Now | — | Redburn Partners | Chris Pitcher | — | Initiates | → Neutral | Get Alert |
| 11/02/2021 | Buy Now | -13.27% | Barclays | — | — | Maintains | Equal-Weight | Get Alert |
| 11/01/2021 | Buy Now | -11.18% | RBC Capital | Nik Modi | — | Maintains | Sector Perform | Get Alert |
| 09/20/2021 | Buy Now | -10.14% | Deutsche Bank | Steve Powers | — | Upgrade | Hold → Buy | Get Alert |
| 08/02/2021 | Buy Now | -12.23% | Deutsche Bank | Steve Powers | — | Maintains | Hold | Get Alert |
FAQ
What is the target price for Colgate-Palmolive (CL) stock?
The latest price target for Colgate-Palmolive (NYSE:CL) was reported by Exane BNP Paribas on June 24, 2024. The analyst firm set a price target for $109.00 expecting CL to rise to within 12 months (a possible 13.90% upside). 33 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Colgate-Palmolive (CL)?
The latest analyst rating for Colgate-Palmolive (NYSE:CL) was provided by Exane BNP Paribas, and Colgate-Palmolive initiated their outperform rating.
When was the last upgrade for Colgate-Palmolive (CL)?
The last upgrade for Colgate-Palmolive Co happened on January 29, 2024 when Raymond James raised their price target to $91. Raymond James previously had a market perform for Colgate-Palmolive Co.
When was the last downgrade for Colgate-Palmolive (CL)?
The last downgrade for Colgate-Palmolive Co happened on May 3, 2022 when Atlantic Equities changed their price target from $92 to $80 for Colgate-Palmolive Co.
When is the next analyst rating going to be posted or updated for Colgate-Palmolive (CL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Colgate-Palmolive, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Colgate-Palmolive was filed on June 24, 2024 so you should expect the next rating to be made available sometime around June 24, 2025.
Is the Analyst Rating Colgate-Palmolive (CL) correct?
While ratings are subjective and will change, the latest Colgate-Palmolive (CL) rating was a initiated with a price target of $0.00 to $109.00. The current price Colgate-Palmolive (CL) is trading at is $95.70, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.